Strengthening Our Global Scientific Footprint: A New Chapter for FBT in 2026

Abstract

As we launch the first issue of Frontiers in Biomedical Technologies (FBT) in 2026, it is my great pleasure to extend my deepest appreciation to all those who have contributed to the continued growth and advancement of the journal. I would especially like to acknowledge our domestic and international authors, whose trust in FBT and whose high-quality manuscripts form the foundation of our scientific achievements. Their contributions represent a diverse global community of researchers, and their commitment to excellence has significantly strengthened the journal’s impact and visibility. My sincere gratitude extends as well to our dedicated reviewers, whose constructive and rigorous evaluations ensure that every published article meets the highest standards of scientific quality. I also thank our readers for their continued engagement, and the editorial and executive teams for their sustained efforts, professionalism, and teamwork throughout the years.

The journal’s performance metrics clearly reflect a strong upward trend in both activity and visibility. According to our quantitative report, the number of submitted articles rose from 32 submissions in 2019 (when we seriously started) to 219 submissions in 2024, marking a remarkable expansion in the journal’s reach and recognition. As submissions increased, our acceptance rate naturally evolved—from 89% in 2019 to 45% in 2023—demonstrating both higher selectivity and our ongoing efforts to strengthen the scientific rigor of the journal.

FBT has also continued to expand its international academic footprint since being indexed in Scopus beginning in 2020. Recent citation analyses (2020–2024) show encouraging improvements in the journal’s citation performance, international collaboration, and the diversity of institutions and countries contributing to and citing our publications. These developments affirm FBT’s growing role as a trusted venue for impactful research in biomedical technologies.

As we move into 2026, we warmly invite researchers, scientists, clinicians, and industry experts to continue submitting their high-quality manuscripts to FBT. Your contributions are essential for advancing innovation in biomedical engineering and for supporting the journal’s mission to disseminate meaningful and influential research. In return, our editorial and executive teams remain dedicated to further enhancing the publication quality, review processes, visibility, and overall scientific impact of FBT. We look forward to a productive year filled with new ideas, strong collaborations, and continued academic progress.